The CD antigens / Cluster of differentiation nomenclature was established in the 1st International Workshop and Conference on Human Leukocyte Differentiation Antigens (HLDA), which was held in Paris in 1982. Today, the HLDA Workshop meeting has been held 10 times and has over 371 CD antigens molecule have been identified. CD antigens for cluster of differentiation, which indicates a defined subset of cellular surface receptors (epitopes) that identify cell type and stage of differentiation, and which are recognized by antibodies.
The CD antigens are protocol used for the identification and investigation of cell surface molecules providing targets for immunophenotyping of cells. CD antigens can act in lot of ways, like as recepters or ligands in terms of physiology. As a siganl, CD antigens usually initiated, altering the behavior of the cell. Some CD proteins do not play a role in cell signaling, but have other functions, such as cell adhesion. CD antigens are used widely for research, immunotherary, tumor and drug target.
Name | Alias | Function |
---|---|---|
CD1b antigens | T6 | Antigen presenting protein |
CD1c antigens | R7, CD1, CD1A, BDCA1 | Non peptide antigen presentation to T-cell receptors on NKT cells. |
CD1d antigens | R3G1 | Antigen presenting protein |
CD2 antigens | T11, LFA-2, SRBC-R, Erythrocyte receptor, LFA-3R | Adhesion between T-cells and other cell types and T-cell activation. |
CD3d antigens | T3D, IMD19, CD3-DELTA | T-cell activation signaling and regulation of TCR expression |
CD3e antigens | T3E, TCRE,CD3 epsilon | T-cell activation signaling and regulation of TCR expression |
CD3G antigens | T3G, IMD17, CD3-GAMMA | T-cell activation signaling and regulation of TCR expression |
CD4 antigens | T4 | T-cell activation, thymic differentiation and receptor for HIV |
CD5 antigens | T1, Tp67, LEU1 | Regulates T-cell receptor signaling |
CD6 antigens | T12, OX52, TP120 | T-cell activation and cell adhesion |
CD7 antigens | LEU 9, GP40, TP41 | T-cell interactions |
CD8a antigens | T8, Leu-2, MAL,CD8 alpha | Co-receptor for MHC class 1 molecules |
CD8b antigens | CD8B1,P37 | Co-receptor for MHC class 1 molecules |
CD9 antigens | p24, MRP-1, 5H9 antigen, MIC3, TSPAN29, GIG2 | Platelet activation and aggregation, and cell adhesion and cell motility |
CD10 antigens | CALLA, NEP, gp100, Neprilysin, SFE, MME, EPN | Peptidase, regulates B-cell growth |
CD11a antigens | LFA-1, LFA1A, ITGAL | Intracellular adhesion and costimulation. |
CD11b antigens | ITGAM, CR3A, MO1A, MAC-1, MAC1A, SLEB6 | Cell adhesion, and immune response |
CD11c antigens | p150, 95, CR4, integrin αX, LFA-1A, ITGAX | Cell adhesion |
CD13 antigens | Aminopeptidase N, APN, ANPEP,PEPN | Aminopeptidase |
CD14 antigens | LPS-R | Receptor for complex of LPS and LBP |
CD15 antigens | LeX, FUT4, ELFT, FCT3A, FUTIV, SSEA-1, FUC-TIV |
CD15 mediates phagocytosis and chemotaxis, found on neutrophils; expressed in patients with Hodgkin disease, some B-cell chronic lymphocytic leukemias, acute lymphoblastic leukemias, and most acute nonlymphocytic leukemias |
CD16a antigens | FcγRIIIA, FCGR3A, FCG3, FCGR3, IGFR3 | Low affinity Fc receptor. Mediates phagocytosis and antibody-dependent T-cell-mediated cytotoxicity |
CD16b antigens | FcγRIIIB, FCGR3B, FCG3, FCGR3, IGFR3 | Low affinity Fc receptor |
CD18 antigens | Integrin β2, ITGB2, MFI7 | Adhesion, cell signaling |
CD19 antigens | B4, Leu-12 | Regulates B-cell development, activation and differentiation. Signal transduction |
CD20 antigens | B1, Bp35, MS4A1 | B-cell activation and proliferation |
CD21 antigens | C3DR, CR2, EBV-R | Signal transduction. Regulator of complement activation |
CD22 antigens | BL-CAM, Siglec-2, Leu-14 | B-cell adhesion and signal transduction |
CD23 antigens | FcεRII, BLAST-2, FCER2, CLEC4J | Low affinity receptor for IgE, ligand for CD19, CD21 and CD81. Key molecule for B-cell activation and growth |
CD24 antigens | BA-1, Nectadrin | Regulation of B-cell proliferation and differentiation |
CD25 antigens | Tac, p55, IL2RA | Receptor for IL2 |
CD26 antigens | DPP IV, DPP4, ADABP, ADCP2 | Exoprotease. HIV pathogenesis |
CD27 antigens | T14, TNFRSF 7, CD27L receptor | Costimulation of B- and T-cell activation |
CD28 antigens | TP44, T44 | T-cell proliferation, survival, IL-2 production, and Th2 cell development |
CD29 antigens | Integrin β1, ITGB1, FNRB | Lymphocyte and endothelial adhesion, lymphocyte trafficking and transvascular migration. |
CD39 antigens | Integrin β1, ITGB1, FNRB | Lymphocyte and endothelial adhesion, lymphocyte trafficking and transvascular migration |
CD30 antigens | Ki-1, TNFRSF8 | Regulates lymphocyte proliferation and cell death. Activation of NF-κB |
CD31 antigens | PECAM-1 | Cell adhesion. Plays a key role in leukocyte trafficking across endothelium |
CD32 antigens | FCG2, FCGR2A1, FCGR2 | Regulation of B-cell function. Induces phagocytosis and mediator release. |
CD32a antigens | FcγRII, FCGR2A,Fc gamma RIIA | Innate and adaptive immune responses |
CD32b antigens | FcγRII, FCGR2B,Fc gamma RIIB | Phagocytosis of immune complexes and regulation of antibody production |
CD33 antigens | p67, Siglec-3 | Cell adhesion, cell-cell signaling, inhibitory receptor, and apoptosis |
CD34 antigens | Cell adhesion | |
CD35 antigens | CR1, C3b/C4b receptor | Receptor for complement components C3b and C4b. Mediates adhesion and phagocytosis |
CD36 antigens | GPIV, GP3B, GP4, SCARB3 | Cell adhesion, cholesterol transport, scavenger receptor |
CD37 antigens | TSPAN26,GP52-40 | Signal transduction. Regulates T-cell proliferation |
CD38 antigens | T10, ADPRC1,ADP ribosyl cyclase 1 | Cell adhesion and signal transduction |
CD39 antigens | NTPDase 1, ENTPD1 | B-cell adhesion. Protects activated cells from lysis |
CD40 antigens | TNFRSF5 | Cell adhesion, cell proliferation, and signal transduction |
CD41 antigens | ITGA2B | Platelet activation and aggregation. |
CD42b antigens | GP1BA, BSS, GP1B, VWDP, BDPLT3 | Cell adhesion, cell activation |
CD42c antigens | GPIbb,GPIBB | Platelet adhesion and aggregation |
CD43 antigens | Leukosialin, sialophorin, SPN | Cell adhesion and T cell activation |
CD44 antigens | H-CAM, Pgp-1, Epican, HUTCH-I, LHR, ECMR-III | Cell adhesion and migration |
CD45 antigens | LCA, T200, B220, PTPRC | Critical for B- and T-cell receptor mediated activation. Regullar of cell growth and differentiation |
CD46 antigens | MCP, TLX | Inhibitory complement activation |
CD47 antigens | IAP, MER6 | Cell adhesion and signal transduction |
CD48 antigens | Blast-1, BCM1 | Cell adhesion and T-cell costimulation |
CD49b antigens | VLA-2, ITGA2 | Adhesion and platelet aggregation. |
CD49c antigens | VLA-3, ITGA3 | Adhesion and signal transduction |
CD49e antigens | VLA-5, ITGA5 | Adhesion, regulation of cell survival and apoptosis |
CD49f antigens | VLA-6, ITGA6 | Embryogenesis, adhesion and cell migration |
CD50 antigens | ICAM-3 | Adhesion and costimulation |
Name | Alias | Function |
---|---|---|
CD51 antigens | Vitronectin receptor, ITGAV, MSK8 | Adhesion and signal transduction |
CD52 antigens | CAMPATH-1, HE5, CDW52 | Complement-mediated cell lysis and antibody-mediated cellular cytotoxicity |
CD53 antigens | Tetraspanin-25, MOX44 | Signal transduction. Cell adhesion, activation, and migration |
CD54 antigens | ICAM-1 | Cell adhesion, lymphocyte activation, and migration |
CD55 antigens | DAF | Regulates complement activation. Signal transduction |
CD56 antigens | NCAM1 | Homophilic and heterophilic adhesion |
CD57 antigens | B3GAT1, GLCATP, GLCUATP, HNK1, LEU7, NK-1, NK1 | Adhesion molecule. |
CD58 antigens | LFA-3 | APC-T-cell adhesion. Killer target cell interaction. |
CD59 antigens | Protectin, MAC- inhibitor | Prevents complement polymerization. Protects cells from complement mediated lysis |
CD59a antigens | ||
CD59b antigens | ||
CD61 antigens | GPIIIa, ITGB3, GP3A | Cell adhesion |
CD62E antigens | E-selectin, ELAM-1, SELE | Tumor cell adhesion and angiogenesis |
CD62L antigens | L-selectin, LECAM-1, SELL | Leukocyte rolling and homing on activated endothelium |
CD62P antigens | P-selectin, PADGEM, SELP, LECAM3 | Cell adhesion |
CD63 antigens | LIMP, LAMP-3, MLA1 | Cell growth and motility regulation; complexes with integrins |
CD64 antigens | FcγRI, FCGR1, FCGR1A | Innate and adaptive immune responses |
CD66a antigens | BGP-1, NCA-160, CEACAM1 | Neutrophil activation, homophilic and heterophilic adhesion |
CD66b antigens | CD67, CGM6, CEACAM8 | Cell adhesion and neutrophil activation |
CD66c antigens | NCA, CEACAM6 |
Cell adhesion and neutrophil activation |
CD66d antigens | CGM1, CEACAM3 | Cell adhesion and neutrophil activation |
CD66e antigens | CEA, CEACAM5 | Homophilic and heterophilic adhesion. May play a role in the metastasis of cancer cells |
CD66f antigens | PSG1, Sp-1, PSBG1 | Cell adhesion, cellular migration, pathogen binding and activation of signaling pathways |
CD68 antigens | Macrosialin, gp110, KP1 | Macrophage homing |
CD69 antigens | AIM, CLEC2C, EA1 | Signal transmission in NK cells and platelets |
CD70 antigens | Ki-24, CD27L, TNFSF7 | Induces proliferation of costimulated T-cells. Enhances the generation of cytotoxic T-cells and contributes to T-cell activation. |
CD71 antigens | T9, TFRC | Controls iron uptake during cell proliferation |
CD72 antigens | Lyb-2, Ly-19, Ly-32 | B-cell activation and proliferation |
CD73 antigens | 5'-nucleotidase, NT5E | Nucleotidase |
CD74 antigens | LN2, Ii, DHLAG | MHC class II antigen processing |
CD75 antigens | ST6GAL1, Sialyltransferase 1 | Functional maturation of B lymphocytes |
CD77 antigens | Gb3, Pk blood group, BLA, A4GALT | Induces apoptosis |
CD79a antigens | MB1, IGA, Ig-alpha | Subunit of B-cell antigen receptor.Signal transduction |
CD79b antigens | B29, IGB, Ig-beta | Subunit of B-cell antigen receptor.Signal transduction |
CD80 antigens | B7, B7-1, BB1 | Costimulation of T-cell activation and proliferation. |
CD81 antigens | TAPA-1, Tetraspanin-28 | Signal transduction and Cell adhesion |
CD82 antigens | R2, KAI1, Tetraspanin-27 | Signal transduction |
CD83 antigens | HB15 | Antigen presentation and immune stimulation |
CD84 antigens | SLAM5 | Homophilic adhesion molecule. Enhances T-cell activation and cytokine production |
CD85a antigens | LILRB3, ILT5, LIR3 | Immune regulation |
CD85c antigens | LILRB5, LIR8 | Immune regulation |
CD85d antigens | LILRB2, ILT4, LIR2, MIR10 | Down regulates the immune response and involved in the development of tolerance |
CD85e antigens | LILRA3, ILT6, LIR4 | May be involved in triggering innate immune responses |
CD85f antigens | LILRA5, ILT11, LIR9 | May be involved in triggering innate immune responses |
CD85i antigens | LILRA1, LIR6 | May be involved in triggering innate immune responses |
CD85j antigens | LILRB1, ILT2, LIR1 | Inhibits cytotoxicity in NK and T cells upon ligand binding |
CD86 antigens | B70, B7-2, CD28LG2 | Costimulation of T-cell activation and proliferation |
CD87 antigens | UPA-R, PLAUR, MO3 | Cell chemotaxis and adhesion |
CD88 antigens | C5A, C5AR, C5R1, C5AR1 | Cell activation |
CD89 antigens | FcαR, FCAR | IgA Fc receptor |
CD90 antigens | Thy-1 | Costimulation of lymphocytes and cell adhesion |
CD91 antigens | LRP1,A2MR,APOER | Endocytic receptor involved in intracellular signaling, lipid homeostasis, and phagocytosis of apoptotic cells |
CD93 antigens | C1qR, C1QR1, MXRA4 | Cell adhesion and clearance of apoptotic cells |
CD94 antigens | KLRD1 | Inhibits NK function |
CD95 antigens | Apo-1, FASLG, APTL, TNFRSF6 | Induces apoptosis |
CD96 antigens | TACTILE | Involved in adhesive interactions of activated T cells and NK cells |
CD97 antigens | ADGRE5 | Neutrophil migration, cell adhesion and signaling |
CD98 antigens | 4F2hc, SLC3A2, MDU1 | Cell activation and cell aggregation |
CD99 antigens | MIC2, E2 | Leukocyte migration, T-cell activation and cell adhesion |
CD100 antigens | Semaphorin 4D, SEMA4D | Enhancement of B-cell and dendritic cell responses |
Name | Alias | Function |
---|---|---|
CD102 antigens | ICAM-2 | Adhesion, costimulation and lymphocyte recirculation |
CD103 antigens | HUMINAE, ITGA1 | Lymphocyte retention. Receptor for E-cadherin. |
CD104 antigens | ITGB4, GP150 | Cell adhesion, and immune response |
CD105 antigens | Endoglin, ENG, END | Angiogenesis. Regulatory component of TGF-beta receptor complex.Modulates cellular response to TGF beta 1 |
CD106 antigens | VCAM-1, L1CAM | Leukocyte adhesion. Transmigration and costimulation of T-cells. |
CD107a antigens | LAMP-1 | Cell adhesion |
CD107b antigens | LAMP-2 | May be involved in leukocyte adhesion.Implicated in tumor cell metastasis |
CD108 antigens | Semaphorin 7A, SEMA7A | Monocyte activator. Negative regulator of T-cell responses. Stimulates axon growth and guidance during development |
CD111 antigens | PVRL1, PRR1, Nectin-1, HVEC | Entry mediator for several herpes viruses (HSV1, HSV2, PRV, BHV1).Believed to be involved in cell adhesion mechanisms |
CD112 antigens | PVRL2, PRR2, Nectin-2, HVEB | Intracellular adhesion, component of adherins junctions. Receptor for herpes simplex virus |
CD113 antigens | PVRL3, Nectin-3 | Adhesion molecule that interacts with afadin |
CD114 antigens | GCSFR, CSF3R | Myeloid cell proliferation and differentiation |
CD15% antigens | M-CSFR, c-fms, CSF1R | Monocytic cell proliferation and differentiation |
CD116 antigens | GM-CSFRα, CSF2RA, GM-CSFR | Myeloid cell hematopoiesis and differentiation |
CD117 antigens | c-kit, SCFR, KIT | Crucial for development of gonadal and pigment stem cells |
CD118 antigens | LIFR, gp190 | Regulates a variety of biological responses including cell proliferation, apoptosis, chemotaxis and adhesion |
CD119 antigens | IFNγR, IFNGR1 | Receptor for interferon gamma, a multifunctional immunomodulator |
CD120a antigens | TNFR-I, TNFRSF1A, TNFR1 | Receptor for TNF |
CD120b antigens | TNFR-II, TNFRSF1B, TNFR2 | Receptor for TNF. Involved in cell differentiation, apoptosis and necrosis |
CD121a antigens | IL-1R type I, IL1R1, IL1R1, IL-1 RI | Receptor for IL1A, IL1B and IL1RN. Mediates IL1 signaling |
CD121b antigens | IL-1R, type II, IL1R2, IL-1R2 |
Receptor for IL1A, IL1B and IL1RN. Mediates IL1 signaling |
CD122 antigens | IL-2Rβ, IL-2RB | Receptor for IL2 and IL15 |
CD123 antigens | IL-3R, IL3RA | Receptor for IL3 |
CD124 antigens | IL4RA, IL4R | Receptor for IL4 and IL13 |
CD125 antigens | IL5RA, IL5R | Receptor for IL5 |
CD126 antigens | IL-6R, IL6R, gp80 | Receptor for IL6 |
CD127 antigens | IL-7R, IL7R | Receptor for IL7 |
CD130 antigens | IL-6Rβ, gp130, IL6ST | Transmits activities of IL6, IL11, LIF and CNF |
CD131 antigens | IL-3R common β, IL3RB, CSF2RB, IL5RB | Component of the high affinity IL3, GM-CSF and IL5 receptors |
CD132 antigens | IL2RG, Common γ | Forms complexes with other cell surface proteins including CD25, CD122, CD124, CD127 and others. Complexes with other cell surface proteins to form receptors for the cytokines IL2, IL4, IL7, IL9, and IL15. |
CD133 antigens | PROM1, RP41, CORD12, PROML1, MSTP061 | CD133 has been proposed to act as an organizer of cell membrane topology. |
CD134 antigens | OX-40, TNFRSF4 | T-cell activation, proliferation and differentiation, apoptosis and cell adhesion |
CD135 antigens | Flt3, Flk2 | Receptor for MSP which regulates cell adhesion, motility, growth, and survival. |
CD136 antigens | MSP-R, RON, PTK8, MST1R | Receptor for MSP which regulates cell adhesion, motility, growth, and survival. |
CD137 antigens | TNFRSF9, 4-1BB, CDw137, ILA | Costimulation of T-cell activation. Regulates T-cell-dependent immune responses. |
CD137L antigens | 4-1BB, TNFRSF9, ILA | Costimulation of T-cell activation |
CD138 antigens | Syndecan-1, SDC | Cell proliferation, cell migration, and cell-matrix interactions |
CD140a antigens | PDGFRα, PDGFRA | Cell proliferation, differentiation and survival |
CD140b antigens | PDGFRβ, PDGFRB | Cell proliferation, differentiation and survival |
CD141 antigens | THBD, AHUS6, BDCA3, THPH12, THRM, TM | Activation of protein C and initiation of protein C anti-coagulant pathway. |
CD142 antigens | Tissue Factor, F3 | Initiates blood clotting |
CD143 antigens | ACE1, DCP, DCP1, ICH, MVCD3 | Converts angiotensin I to angiotensin II by release of terminal His-Leu, which results in an increase of the vasoconstrictor activity of angiotensin. Cell adhesion. |
CD144 antigens | VE-Cadherin, Cadherin-5 | Cell adhesion. |
CD146 antigens | MUC18, S-endo, MCAM | Cell adhesion. Involved in heterophilic cell to cell interactions |
CD147 antigens | Neurothelin, basoglin, Basigin, BSG,EMMPRIN | Cell adhesion and T-cell activation |
CD148 antigens | HPTP-eta, DEP1, PTPRJ | Tyrosine phosphatase cell signaling, cell growth and differentiation, mitotic cycle and oncogenic transformation |
CD150 antigens | SLAM, SLAMF1, IPO-3 | Costimulation of T-cells and B-cells |
Name | Alias | Function |
---|---|---|
CD151 antigens | PETA-3, GP27, SFA-1, | Cell adhesion. |
CD152 antigens | CTLA-4 | T-cell inhibition |
CD153 antigens | CD30L, TNFSF8 | Binds to CD30 and induces proliferation of T-cells |
CD154 antigens | CD40L, CD40 Ligand, gp39, TRAP | Mediates B-cell proliferation, IgE production and is involved in immunoglobulin class switching |
CD155 antigens | PVR, NECL-5 | Mediates NK cell adhesion and triggers their effector functions. |
CD156a antigens | ADAM8 | Possible involvement in extravasation of leukocytes |
CD156b antigens | ADAM17, ADAM18, CSVP, NISBD, NISBD1, TACE | Cleaves transmembrane form of TNF-α to generate the soluble active form. |
CD156c antigens | ADAM10 | Metalloprotease activity, cleaves many proteins including TNF-α and E-cadherin |
CD157 antigens | BST-1 | Synthesis of cyclic ADP-ribose and putative involvement in pre-B-cell growth |
CD158a antigens | p58.1, KIR2DL1 | Inhibits the activity of NK cells |
CD158b2 antigens | NKAT-2, KIR2DL3 | Inhibits the activity of NK cells |
CD158d antigens | KIR2DL4, KIR-103AS | Inhibits the activity of NK cells |
CD158e antigens | KIR3DL1 | Receptor on natural killer cells for HLA Bw4 allele. Inhibits the activity of natural killer cells thus preventing cell lysis. |
CD158z antigens | KIR3DL3 | Inhibits the activity of NK cells |
CD159a antigens | NKG2A, KLRC1, NKG2 | Negative regulation of NK cell activation |
CD160 antigens | BY55, NK1 | Broad specificity receptor for MHC class I molecules |
CD161 antigens | NKR-P1A, KLRB1 | Inhibits NK cell mediated cytotoxicity. Induces immature thymocyte proliferation |
CD162 antigens | PSGL-1, SELPLG | Mediates rapid rolling of leukocytes over vascular surfaces during inflammation |
CD163 antigens | M130, MM130 | Clearance and endocytosis of hemoglobin / haptoglobin complexes by macrophages. |
CD164 antigens | MGC-24, MUC-24 |
Facilitates the adhesion of CD34+ cells to the stroma and negatively regulates their proliferation |
CD166 antigens | ALCAM | Mediates cell adhesion by binding to CD6 for intrathymic T-cell development |
CD167a antigens | DDR1, MCK10 | Receptor tyrosine kinase involved in cell-cell interactions |
CD167b antigens | DDR2 | Receptor tyrosine kinase involved in cell-cell interactions |
CD170 antigens | Siglec-5, CD33-like2, SIGLEC5, OB-BP2 | Adhesion molecule mediating sialic-acid dependent binding to cells |
CD171 antigens | NCAM-L1, L1CAM | Multidomain cell adhesion molecule required for normal neurohistogenesis |
CD172a antigens | SIRPα, SHPS-1, SIRPA | Immunoglobulin-like cell surface receptor for CD47. Supports adhesion of cerebellar neurons, neurite outgrowth and glial cell attachment. |
CD172b antigens | SIRPβ, SIRB1 | Immunoglobulin-like cell surface receptor for CD47. Supports adhesion of cerebellar neurons, neurite outgrowth and glial cell attachment. |
CD172g antigens | SIRPγ, SIRPB2 | Immunoglobulin-like cell surface receptor that mediates cell-cell adhesion on binding with CD47 |
CD176 antigens | Thomson Friedrenreich Ag, TRF1, TRF | Potentially involved in cell adhesion |
CD177 antigens | NB1 glycoprotein, HNA-2a | Major immunogenic molecule of neutrophil membrane |
CD178 antigens | FasL, CD95L, FASLG, Fas Ligand | T-cell mediated cytotoxicity |
CD179a antigens | VPREB1, IGI, IGVPB, VPREB | |
CD179b antigens | IGLL1 | Early B-cell differentiation. |
CD180 antigens | RP-105 | Controls B-cell recognition and signaling of LPS. Leads to NFkB activation. |
CD181 antigens | CXCR1, C-C, CD128, CKR-1, IL8R1, IL8RA, CMKAR1, IL8RBA, CDw128a, C-C-CKR-1 | CD181 is a member of the G-protein-coupled receptor family, and a receptor for interleukin 8 (IL8). |
CD182 antigens | IL-8, GRO-α, β, γ, GCP-2, NAP-2, ENA-78 | CD182 is a member of the G-protein-coupled receptor family, and a receptor for interleukin 8 (IL8) |
CD183 antigens | CXCR3 | T-cell chemotaxis, integrin activation, and adhesion |
CD184 antigens | CXCR4, FB22, HM89, LAP3, LCR1, NPYR | CD184 is an alpha-chemokine receptor specific for stromal-derived-factor-1 (SDF-1 also called CXCL12), a molecule endowed with potent chemotactic activity for lymphocytes. |
CD185 antigens | CXCR5, BLR1 | Homing and cell movement |
CD186 antigens | CXCR6, BONZO, STRL33, TYMSTR | B-cell development |
CD191 antigens | CCR1, MIP-1αR, RANTES-R | Chemotaxis, adhesion |
CD192 antigens | CCR2, MCP-1-R | Leukocyte chemotaxis and is an HIV co-receptor |
CD193 antigens | CCR3,CCL11, CCL7, CCL13, CCL5, HIV-1 | CD193 is a receptor for C-C type chemokines.CD193 is also known to be an entry co-receptor for HIV-1. |
CD194 antigens | CCR4, CKR4, K5-5, CMKBR4, ChemR13 | CD194 is a receptor for C-C type chemokines. |
CD195 antigens | CCR5, CKR5, CCCKR5, CMKBR5, IDDM22 | The CD195 belongs to the beta chemokine receptors family of integral membrane proteins. |
CD196 antigens | CCR6, BN-1, CKR-L3, CKRL3, CMKBR6, DCR2, DRY6, GPR29, GPRCY4, STRL22 | Receptor for a C-C type chemokine. Binds to MIP-3-alpha/LARC and affects dendritic cell chemotaxis. |
CD197 antigens | CCR7, BLR2, EBI1, CDw197, CMKBR7 | The protein encoded by this gene is a member of the G protein-coupled receptor family. |
CD200 antigens | OX-2, OX2 | Down-regulatory signal for myeloid cell function, costimulates T-cell proliferation |
Name | Alias | Function |
---|---|---|
CD201 antigens | EPC-R, PROCR | Enhances protein C activation |
CD202b antigens | Tie2, Tek | Signaling, migration and adhesion |
CD204 antigens | Macrophage scavenger-R, MSR1 | Endocytosis of macromolecules including low density lipoproteins, host defense |
CD205 antigens | DEC-205, LY75 | Phagocytosis, endocytosis |
CD206 antigens | MRC1, MMR, MRC1L1, CLEC13D, CLEC13DL | Cell adhesion, cell-cell signalling |
CD207 antigens | Langerin | Pathogen receptor and processing of antigen for presentation to T-cells |
CD208 antigens | DC-LAMP, LAMP3 | Dendritic cell maturation marker, involved in cell proliferation |
CD209 antigens | DC-SIGN | Mediates antigen endocytosis and degradation binds pathogenic antigens such as HIV1 gp120 |
CD210 antigens | IL10RA; IL10R; CD210a; HIL-10R; IL-10R1 | CD210 is tha receptor of IL-10. |
CD212 antigens | IL-12-R β1, IL12RB1 | Forms part of the receptor complexes for IL12 and IL23 |
CD213a1 antigens | IL-13-R α1, IL13RA1 | Forms part of the receptor complexes for IL13 and IL4 |
CD213a2 antigens | IL-13-R α2, IL13RA2 | Forms part of the receptor complex for IL13. |
CD215 antigens | IL15RA | Receptor for IL15. |
CD217 antigens | IL-17R, IL17RA | Receptor for IL17A and IL17F |
CD218a antigens | IL-18Rα, IL-1Rrp, IL18R1 | Forms part of the receptor complex for IL18 |
CD218b antigens | IL-18Rβ, IL18RAP | Forms part of the receptor complex for IL18 |
CD220 antigens | Insulin-R, Insulin Receptor, IINSR | Insulin receptor |
CD221 antigens | IGF-1 R, IGF1R | Receptor for IGF-I and IGF-II. Mediates mitogenic and anti-apoptotic signals |
CD223 antigens | LAG-3 | Involved in lymphocyte activation, negative regulation of T-cell activation |
CD224 antigens | GGT1 | Catalyzes the transfer of the glutamyl moiety of glutathione to a variety of amino acids and dipeptide acceptors, which contributes to oxidative homeostasis. |
CD225 antigens | IFITM1, Leu-13, DSPA2a | Cell adhesion, cell growth and migration. Relays antiproliferative and homotypic adhesion signals |
CD226 antigens | DNAM-1, PTA-1, TLiSA1 |
Intercellular adhesion, lymphocyte signaling, cytotoxicity and lymphokine secretion mediated by cytotoxic T-cells and NK cells |
CD227 antigens | MUC1, EMA, PUM, Mucin 1 | Cell adhesion and signaling |
CD228 antigens | Melanotransferrin, MFI2 | Involved in cellular iron uptake |
CD229 antigens | Ly-9, LY9, SLAMF3 | Adhesion between T-cells and accessory cells |
CD230 antigens | Prion protein, PRNP | Oxidative stress homeostasis,cell survival, and signal transduction |
CD231 antigens | TALLA-1, A15, Tspan-7, | Cell proliferation and motility |
CD233 antigens | Band 3, SLC4A1 | Anion exchanger across the cytoplasmic membrane, binding site for cytoskeletal proteins, enzymes and hemoglobin |
CD235a antigens | Glycophorin A, GYPA | Major erythrocyte intrinsic membrane protein. Minimizes erythrocyte aggregation, receptor for influenza virus, Plasmodium falciparum and Hepatitis A virus |
CD236 antigens | Glycophorin C/D, GYPC | Glycophorin-C regulates the stability of red cells |
CD238 antigens | Kell, KEL, Blood Group Kell | Zinc endopeptidase cleaving endothelin 3. Contains the Kell blood group antigens |
CD239 antigens | B-CAM, BCAM | Laminin alpha-5 receptor |
CD242 antigens | ICAM-4 | Ligand for the leukocyte adhesion protein LFA-1 |
CD244 antigens | 2B4, NAIL | NK cell activation, NK cell and T-cell interaction |
CD247 antigens | TCRz, CD3-ZEETA | Couples antigen recognition to several intracellular signaling pathways |
CD249 antigens | Aminopeptidase AM, EAP, ENPEP | Converts angiotensin II to angiotensin III. |
Name | Alias | Function |
---|---|---|
CD252 antigens | OX40L, gp34 | Ligand for receptor TNFRSF4. Co-stimulates T-cell proliferation and cytokine production |
CD253 antigens | TRAIL, Apo-2L, TL2, TNFSF10 | Induces cell death by apoptosis |
CD254 antigens | TNFSF11, RANKL, OPGL, ODF | Involved in dendritic cell maturation |
CD256 antigens | APRIL, TALL-2, TRDL-1, TNFSF13 | Important for B cell development |
CD257 antigens | BLyS, BAFF, TALL-1, TNFSF13B | Involved in the stimulation of B- and T-cell function and the regulation of humoral immunity |
CD258 antigens | LIGHT, HVEM-L, TNFRSF14 | Stimulates T-cell proliferation, receptor for Herpes simplex virus |
CD261 antigens | TRAIL-R1, DR4, TNFRSF10A | Induces apoptosis, promotes activation of NFkB |
CD262 antigens | TRAIL-R2, DR5, TNFRSF10B | Activated by TNFSF10 / TRAIL and transduces apoptosis signal |
CD264 antigens | DCR2, TRAIL-R4, TNFRSF10D | Receptor for TRAIL, inhibits apoptosis |
CD265 antigens | RANK, TRANCE-R, ODFR, TNFRSF11A | Receptor for TRANCE. Enhances T-cell growth and dendritic cell function, plays a role in lymph node organogenesis |
CD266 antigens | TWEAK-R, FGF-inducible 14, TNFRSF12A | Receptor for TWEAK. Promotes angiogenesis and the proliferation of endothelial cells. |
CD267 antigens | TACI, TNFR SF13B, TNFRSF13B | Receptor for CD256 and CD257, mediates activation of the transcription factors NFAT, AP1, and NFkB. |
CD268 antigens | BAFFR, TR13C,TNFRSF13C | B-cell receptor for CD257. B-cell response |
CD269 antigens | BCMA, TNFRSF13B, TNFRSF17 | Receptor for CD256 and CD257, activates NFkB and JNK. |
CD270 antigens | HveA, TR2, TNFRSF14 | Receptor for CD258 and CD272. |
CD271 antigens | NGFR, p75 (NTR) | Regulates neuronal growth, migration, differentiation and cell death during stem cells. |
CD272 antigens | BTLA | Lymphocyte inhibitory receptor |
CD273 antigens | B7DC, PD-L2, PDCD1L2 | Stimulatory on dendritic cells, inhibits T-cell activation upon engaging the PD1 receptor. |
CD274 antigens | B7-H1, PD-L1 | Found on activated T cells, B cells, and myeloid cells, to modulate activation or inhibition |
CD275 antigens | B7-H2, ICOSL, B7-RP1, GL50 |
Ligand for CD278. Costimulatory signal for T-cell proliferation and cytokine secretion, induces B-cell proliferation and differentiation |
CD276 antigens | B7-H3 | Enhances the induction of cytotoxic T-cells and selectively stimulates interferon gamma production in the presence of T-cell receptor signaling |
CD277 antigens | BTN3A1, butyrophilin SF3 A1, BTF5 | T-cell activation |
CD278 antigens | ICOS, AILIM | Mediate cell-cell interactions, and effective help for antibody secretion by B-cells |
CD279 antigens | PD1, SLEB2 | Inhibitory cell surface receptor involved in T-cell tolerance |
CD281 antigens | TLR1 | Pathogen recognition and activation of innate immunity, regulates TLR2 function |
CD282 antigens | TLR2 | Mediator of innate immunity against bacterial cell wall lipoproteins. Induces activation of NFkB |
CD283 antigens | TLR3 | Mediator of innate immunity against viral infection, activated by dsDNA |
CD284 antigens | TLR4 | Mediator to innate immunity against bacterial polysaccharides. Induces activation of NFkB and production of type I interferons |
CD286 antigens | TLR6 | Receptor functionally interacts with toll-like receptor 2 to mediate cellular response to bacterial lipoproteins |
CD292 antigens | BMPR1A, ALK3, SKR5 | Receptor for BMP-2 and BMP-4 |
CD294 antigens | PTGDR2, DP2, DL1R, CRTH2, GPR44 | Regulates immune and inflammatory response, induces Th2 cells, eosino and baso migration |
CD295 antigens | LeptinR, LEPR, OB-R, Leptin Receptor | Receptor for leptin. Involved in the regulation of fat metabolism and required for normal lymphopoiesis |
CD296 antigens | ART1,ARTC1 | Catalyzes the transfer of ADP-ribose from NAD+ to arginine residues in proteins |
CD297 antigens | ART4, dombrock blood group | Plays a role in the metabolism of Dombrock blood group antigen |
CD298 antigens | ATP1B3, ATPB-3 | Component of Na+-K+ pump on neuronal membranes. |
CD299 antigens | DC-SIGN-related, LSIGN, DC-SIGN2, CLEC4M, DC-SIGNR | Pathogen-recognition receptor involved in peripheral immune surveillance in liver. Recognizes mannose N-linked oligosaccharides in HIV-1, HIV-2, human cytomegalovirus and human SARS coronavirus |
CD300a antigens | CMRF35H, IRC1, IRp60M, CLM-8 | NK cell function; also suppresses the effects of eotaxin, IL-5 and GM-CSF on neutrophils; and inhibits Ig-E dependent |
CD300b antigens | CLM-7, IREM3, LMIR5, CMRF35-A2 | Activating immune receptor by interaction with TYROBP |
CD300c antigens | CMRF35A, LIR, CLM-6 | Regulates IFN-alpha and TNF-alpha secretion by plasmacytoid dendritic cells |
CD300e antigens | CMRF35L, CLM-2, CMRF35-A5 | Prevents apoptosis, triggers the production of pro-inflammatory cytokines and upregulates the expression of cell surface co-stimulatory molecules |
CD300f antigens | CLM-1, IREM-1, LMIR3 | Inhibitory receptor for myeloid cells and mast cells. Inhibits osteoclast formation |
CD300g antigens | CLM-9, TREM4 | May mediate L-selectin-dependent lymphocyte rollings |
Name | Alias | Function |
---|---|---|
CD301 antigens | MGL, HML, CLEC10A, MGL1 | Cell adhesion, cell-cell signaling and cellular recognition through glycoprotein binding |
CD302 antigens | DCL1, BIMLEC | Cell adhesion and migration |
CD304 antigens | BDCA4, neuropilin 1, CLEC4C, NRP1 | Angiogensis, axon guidance, cell survival, migration, and invasion |
CD305 antigens | LAIR1 | Negative regulator of NK, B, and T cells |
CD306 antigens | LAIR2 | Inhibits cellular activation and inflammation |
CD307 antigens | IRTA2, FCRL5 | May function in B-cells activation and differentiation |
CD307a antigens | FCRL1 | May function in B-cells activation and differentiation. |
CD307b antigens | FCRL2 | May function in B-cells activation and differentiation. |
CD309 antigens | VEGFR2, KDR, FLK-1 | Activation of this receptor by VEGF plays a role in angiogenesis, development, wound healing, cell proliferation, migration and differentiation |
CD312 antigens | ADGRE2, VBU, EMR2 | Involved in immune and inflammatory response |
CD314 antigens | NKG2D, KLRK1 | Receptor for the recognition of MHC class I HLA-E molecules by NK cells and some cytotoxic T-cells |
CD315 antigens | PTGFRN, CD9P-1, EWI-F, FPRP, SMAP-6 | Inhibits binding of prostaglandin F2-alpha (PGF2-alpha) to its specific FP receptor. |
CD316 antigens | EWI2, PGRL, CD81P3, KASP,IGSF8, EWI-2, KCT-4 | Negative regulator of cell motility. |
CD317 antigens | BST2, HM1.24 | IFN-induced antiviral host restriction factor |
CD318 antigens | CDCP1, SIMA135 | Cell differentiation, homing and dissemination. May also have a pro-survival role |
CD319 antigens | CRACC, SLAMF7 | Mediates NK cell activation and may play a role in lymphocyte adhesion |
CD320 antigens | FDC-SM-8D6, TCbIR, 8D6 antigen | Augments the proliferation of plasma cell precursors generated by IL10. Receptor for the cellular uptake of transcobalamin bound cobalamin |
CD321 antigens | JAM-A, JAM-1, PAM-1, F11R | Plays a role in epithelial tight junction formation, regulation of leukocyte erythrocytes. migration, epithelial barrier maintenance and platelet activation |
CD322 antigens | JAM-B, JAM-2, VE-JAM | May play a role in lymphocyte homing to secondary lymphoid organs |
CD324 antigens | E-Cadherin, Uvomorulin, CDH1, E-cad | Calcium-dependent cell adhesion protein |
CD325 antigens | N-Cadherin, NCAD, CDH2 |
In hippocampal cells, pancreatic cells and hepatocytes |
CD326 antigens | Ep-CAM, Ly74,, EGP314, TROP-1, TACSTD1 | A homotypic calcium-independent T-cell adhesion molecule |
CD327 antigens | SIGLEC6, OB-BP1 | Adhesion molecule that mediates sialic-acid dependent binding to cells |
CD331 antigens | FGFR1, Fms-like tyrosine kinase-2, KAL2, N-SAM | Receptor for basic fibroblast growth factor. |
CD332 antigens | FGFR2, BEK, KGFR | Cell-surface receptor for fibroblast growth factors |
CD333 antigens | FGFR3, ACH, CEK2 | Cell-surface receptor for fibroblast growth factors |
CD334 antigens | FGFR4, JTK2, TKF | Cell-surface receptor for fibroblast growth factors |
CD335 antigens | NCR1, LY94, NKP46, NK-p46 | NK cell activation |
CD336 antigens | NKp44, Ly-95 homolog, NCR2 | Cytotoxicity-activating receptor that may contribute to the increased efficiency of activated NK cells to mediate tumor cell lysis |
CD337 antigens | NKp30, Ly117, NCR3 | Cytotoxicity-activating receptor that contributes to the increased efficiency ofactivated NK cells to mediate tumor cell lysis |
CD338 antigens | ABCG2, BCRP, Bcrp1, MXR | Xenobiotic transporter that may play an important role in the exclusion of xenobiotics from the brain and cancer cells |
CD339 antigens | Jagged-1, JAG1, JAGL1, hJ1 | Ligand for multiple Notch receptors. Involved in the mediation of Notch signaling, cell fate determination in hematopoiesis and cardiovascular development |
CD340 antigens | ERBB2, MLN 19 | Binds tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signaling pathways |
CD344 antigens | Frizzled-4, Fz-4, FzD4 | Receptor for Wnt proteins |
CD350 antigens | Frizzled-10, Fz-10, FZD10 | Receptor for Wnt proteins |
CD351 antigens | FCAMR, Fcα/μR | Fc receptor that binds IgM with high affinity and IgA with a 10-fold lower affinity |
CD352 antigens | NTB-A, SLAMF6, LY108 | Triggers cytolytic activity only in NK cells expressing high surface densities of natural cytotoxicity receptors |
CD353 antigens | SLAMF8 | Regulates macrophage function; may play a role in B cell lineage commitment |
CD354 antigens | TREM-1 | Stimulates neutrophil and monocyte-mediated inflammatory responses.Triggers release of pro-inflammatory chemokines and cytokines, as well as increased surface expression of cell activation markers |
CD355 antigens | CRTAM | Interaction with CADM1 promotes NK cell cytotoxicity and IFN-gamma secretion by CD8+ cells in vitro as well as NK cell-mediated rejection of tumors expressing CADM3 in vivo |
CD357 antigens | TNFRSF18, GITR | Receptor for TNFSF18 |
CD358 antigens | TNFRSF21 | May activate NFkB and promote apoptosis. May activate JNK and be lymphocytes. involved in T-cell differentiation. Required for both normal cell body death and axonal pruning |
CD360 antigens | IL-21R | Receptor for interleukin-21. |
CD361 antigens | EVI2, BEVDB, D17S376 | Cell adhesion, and immune response. |
CD362 antigens | Syndecan-2, HSPG, SDC2 | Cell surface proteoglycan that bears heparan sulfate |
CD365 antigens | HAVCR1, HAVCR, KIM-1, TIM, TIM-1, TIMD1 | as a stimulatory molecule for T-cell activation |
CD366 antigens | TIM-3, TIMD3 | T-cell exhaustion, immune checkpoint |
CD367 antigens | DCIR, DDB27, CLECSF6, CLEC4A | cell adhesion, cell-cell signalling, glycoprotein turnover, and roles in inflammation and immune response |
CD368 antigens | MCL, CLECSF8, CLEC-6, MPCL, CLEC4D | cell adhesion, cell-cell signalling, glycoprotein turnover, and roles in inflammation and immune response |
CD369 antigens | DECTIN-1, CLECSF12, CLEC7A | cell adhesion, cell-cell signalling, glycoprotein turnover, and roles in inflammation and immune response |
CD370 antigens | HEEE9341, UNQ9341, DNGR1, CLEC9A | cell adhesion, cell-cell signalling, glycoprotein turnover, and roles in inflammation and immune response |
CD371 antigens | CLL-1, MICL, DCAL-2, CLEC12A | cell adhesion, cell-cell signalling, glycoprotein turnover, and roles in inflammation and immune response |